FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry and represents a method for introducing gold nanoparticles into the body by the local skin application, differing by applying the preparation of the following composition: 96% dimethyl sulphoxide 0.1 ml per a gel base 1 ml with gold nanoparticles d=140 nm, or the preparation of the following composition: 20% thiophane sulphoxide 0.1 ml per a gel base 1 ml with gold nanoparticles d=40 nm; the skin areas coated with gold nanoparticles in complex with organic sulphur compounds shall be exposed to ultrasound at frequency 1 MHz, power 2 Wt and length 2 minutes.
EFFECT: invention provides higher transdermal permeability of gold nanoparticles and no nanoparticle accumulation in the internal organs.
8 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR TRANSDERMAL DELIVERY OF NANOPARTICLES | 2021 |
|
RU2753699C1 |
METHOD FOR SURFACE MYCOSIS THERAPY | 2020 |
|
RU2749481C1 |
COMPOSITE NANOPARTICLES FOR PHOTODYNAMIC DIAGNOSIS | 2011 |
|
RU2463074C1 |
PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 |
|
RU2617045C1 |
MEDICINAL PREPARATION IN FORM OF SOL FOR TREATING A DISEASE AND/OR CONDITION CHARACTERIZED BY VIOLATION OF SKIN INTEGRITY, AND A METHOD FOR PREPARING IT | 2019 |
|
RU2742752C1 |
METHOD FOR ASSESSING COPPER NANOPARTICLES ADMINISTRATION SAFETY | 2011 |
|
RU2477485C2 |
METHOD FOR PLASMON-RESONANCE PHOTOTHERMAL TUMOUR THERAPY IN EXPERIMENT | 2015 |
|
RU2614507C1 |
METHOD FOR COMPLEX CORRECTION OF NON-SCARRING ALOPECIA IN EXPERIMENT | 2023 |
|
RU2821779C1 |
METHOD FOR SIMULATING LIVER METASTASES EXPERIMENTALLY | 2013 |
|
RU2538243C1 |
METHOD OF STIMULATING SKIN AND MUCOUS LINING DEFECT REPAIR AND MEDICINAL AGENT FOR REALISING SAID METHOD | 2011 |
|
RU2447082C1 |
Authors
Dates
2013-12-10—Published
2012-10-01—Filed